CIK 0000875045
- Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330112644
- Phone
- +1 617-679-2000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-09-22 | DORSA CAROLINE Director | Exercise or conversion · Stock Option (Right to Buy) | −2,570 | 0 | ||
| 2016-09-22 | DORSA CAROLINE Director | Exercise or conversion · Stock Option (Right to Buy) | −25,000 | 0 | ||
| 2016-07-21 | SCANGOS GEORGE A Chief Executive Officer | Sale | −157 | $280.00 | $44K | 54,779 |
| 2016-06-08 | DENNER ALEXANDER J Director | Grant or award | +1,060 | 8,950 | ||
| 2016-06-08 | SHERWIN STEPHEN A Director | Grant or award | +1,060 | 5,905 | ||
| 2016-06-08 | SCHENK LYNN Director | Grant or award | +1,060 | 5,950 | ||
| 2016-06-08 | Rowinsky Eric K Director | Grant or award | +1,060 | 13,065 | ||
| 2016-06-08 | PAPADOPOULOS STELIOS Director | Grant or award | +1,590 | 18,170 | ||
| 2016-06-08 | Mulligan Richard Director | Grant or award | +1,060 | 8,950 | ||
| 2016-06-08 | LEAMING NANCY Director | Grant or award | +1,060 | 8,984 | ||
| 2016-06-08 | DORSA CAROLINE Director | Grant or award | +1,060 | 17,093 | ||
| 2016-06-08 | PANGIA ROBERT W Director | Grant or award | +1,060 | 16,628 | ||
| 2016-06-08 | Posner Brian S Director | Grant or award | +1,060 | 6,335 | ||
| 2016-06-06 | Koppel Adam EVP, Strategy and Bus. Dev. | Sale | −555 | $290.00 | $161K | 2,402.11 |
| 2016-06-03 | SCANGOS GEORGE A Chief Executive Officer | Sale | −842 | $290.00 | $244K | 54,936 |
| 2016-06-02 | Koppel Adam EVP, Strategy and Bus. Dev. | Exercise or conversion | +1,643 | 3,491.11 | ||
| 2016-06-02 | Koppel Adam EVP, Strategy and Bus. Dev. | Shares withheld for taxes | −534 | $289.73 | $155K | 2,957.11 |
| 2016-06-02 | Koppel Adam EVP, Strategy and Bus. Dev. | Exercise or conversion · Restricted Stock Unit | −1,643 | 5,585 | ||
| 2016-06-02 | Koppel Adam EVP, Strategy and Bus. Dev. | Other disposition · Restricted Stock Unit | −1,969 | 3,616 | ||
| 2016-06-01 | Ehlers Michael D EVP, Research and Development | Grant or award | +3,034 | 3,034 |
Page 69 of 73 · 1,456 trades